- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![D-erythro-hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidenum)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]- , 1,1-dimethylethylus ester](/upload/6698/d-erythro-hexonic-acid-2-4-6-trideoxy-3-5-o-1-methylethylidene-6-5-methyl-1-3-4-thiadiazol-2-yl-sulfonyl-1-1-dimethylethyl-ester_515974.gif "D-erythro-hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidenum)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]- , 1,1-dimethylethylus ester")
D-erythro-hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidenum)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]- , 1,1-dimethylethylus ester
Product Name:D-erythro-hexonic acidum 2,4,6-trideoxy-3,5-O-(1-methylethylidenum)-6-[(5-methyl-1,3,4-thiadiazol-2-yl) sulfonyl] -, 1,1-dimethylethyl ester
Formulae hypotheticae: C16H26N2O6S2
Molecular pondus:406.52
CAS Subcriptio Number:1326302-97-9
(4R-cis) -6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acidum tert-Butyl Ester
Product Name:(4R-cis) -6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acidum tert-Butyl Ester
Formulae hypotheticae: C13H23ClO4
Molecular Weight:278.77
CAS Subcriptio Number:154026-94-5
![5-(Bromomethyl) -4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine](/upload/6698/5-bromomethyl-4-4-fluorophenyl-6-isopropyl-2-methyl-methylsulfonyl-amino-pyrimidine_762247.gif "5-(Bromomethyl) -4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine")
5-(Bromomethyl) -4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine
Product Name:5-(Bromomethyl) -4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine
Formulae hypotheticae: C16H19BrFN3O2S
Molecular pondus:416.31
CAS Registry Number: 799842-07-2
![4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl](/upload/6698/4-4-fluorophenyl-6-isopropyl-2-n-methyl-n-methylsulfonyl-amino-pyrimidinyl-5-yl-formyl_847387.gif "4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl")
4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl
Product Name:4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl
Formulae hypotheticae: C16H18FN3O3S
Molecular pondus:351.4
CAS Subcriptio Number:147118-37-4
![Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylatus](/upload/6698/methyl-4-4-fluorophenyl-6-isopropyl-2-n-methyl-n-methylsulfonyl-amino-pyrimidine-5-carboxylate_296545.gif "Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylatus")
Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylatus
Product Name:Methyl 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-carboxylatum
Formulae hypotheticae: C17H20FN3O4S
Pondus hypotheticum: 381.42
CAS Registry Number: 289042-11-1
tert-Butyl rosuvastatin
Product Name: tert-Butyl rosuvastatin
Formulae hypotheticae: C26H36FN3O6S
Molecular pondus:537.64
CAS Subcriptio Number:355806-00-7
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
